Our innovation
We innovate with purpose to lead where medicine is going.
Our diverse portfolio spans Oncology, Immunology, Neuroscience, Cardiopulmonary and Specialty Ophthalmology.
Our discovery, product development and supply process
With our cross-functional approach to innovation, deep expertise, and global footprint, we aim to develop therapies for patients by inventing, licensing and acquiring new molecular entities and exploring new pathways and multi-modality treatment approaches.
Play video
Our discovery, product development and supply process
Play video
Our discovery, product development and supply process
We believe there are no limits to what science can do. We work to bring breakthroughs beyond medicine to help transform patients’ lives.
Our robust pipeline spans multiple focus areas with a number of programs in development, as well as select novel therapy programs recently approved, or with potential filings in the United States/European Union.
Data science and digital health accelerate our R&D engine across the entire value-chain – from target discovery and patient segmentation to drug design, CMC process optimization and all facets of clinical development.
Latest news
Our R&D leadership team is made up of passionate individuals who are helping to transform the future of healthcare.